High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels of α 1-Antitrypsin with Negligible Toxicity

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Human Gene Therapy

• Publication date

  1998-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/hum.1998.9.18-2709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity

  1998influential reference
• Toxicological Comparison of E2a-Deleted and First-Generation Adenoviral Vectors Expressing α 1-Antitrypsin after Systemic Delivery

  1998cited by this paper
• In Vitro and In Vivo Biology of Recombinant Adenovirus Vectors with E1, E1/E2A, or E1/E4 Deleted

  1998cited by this paper
• Immune Responses to Reporter Proteins and High Viral Dose Limit Duration of Expression with Adenoviral Vectors: Comparison of E2a Wild Type and E2a Deleted Vectors

  1997cited by this paper
• Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses

  1997cited by this paper
• Persistence in muscle of an adenoviral vector that lacks all viral genes.

  1997cited by this paper
• Construction of adenovirus vectors through Cre-lox recombination

  1997cited by this paper
• Persistent transgene expression in mouse liver following in vivo gene transfer with a ΔE1/ΔE4 adenovirus vector

  1997cited by this paper
• A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal.

  1996influential reference
• Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice

  1996cited by this paper
• A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.

  1996cited by this paper
• Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis.

  1996cited by this paper
• In Vivo Expression of Full-Length Human Dystrophin from Adenoviral Vectors Deleted of All Viral Genes

  1996cited by this paper
• Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit

  1996cited by this paper
• A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4

  1996cited by this paper
• In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes.

  1996cited by this paper
• Sustained expression of therapeutic levels of human factor VIII in mice.

  1996cited by this paper
• Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre

  1996cited by this paper
• Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs.

  1996cited by this paper
• Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells.

  1996cited by this paper
• A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions.

  1995cited by this paper
• Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector.

  1995cited by this paper
• Characterization of an Adenovirus Gene Transfer Vector Containing an E4 Deletion

  1995cited by this paper
• Therapeutic serum concentrations of human alpha‐1‐antitrypsin after adenoviral‐mediated gene transfer into mouse hepatocytes

  1995cited by this paper
• Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

  1995cited by this paper
• Transfer of the CFTR Gene to the Lung of Nonhuman Primates with E1-Deleted, E2a-Defective Recombinant Adenoviruses: A Preclinical Toxicology Study

  1995cited by this paper
• Development of Cell Lines Capable of Complementing E1, E4, and Protein IX Defective Adenovirus Type 5 Mutants

  1995cited by this paper
• Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

  1994cited by this paper
• MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

  1994cited by this paper
• Mobile inverted-repeat elements of the Tourist family are associated with the genes of many cereal grasses.

  1994cited by this paper
• Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.

  1994cited by this paper
• Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.

  1993cited by this paper
• Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

  1993cited by this paper
• Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice.

  1993cited by this paper
• Adenovirus–mediated in vivo gene transfer and expression in normal rat liver

  1992cited by this paper
• Hepatic Gene Therapy: Persistent Expression of Human α1-Antitrypsin in Mice after Direct Gene Delivery In Vivo

  1992cited by this paper
• Comparison of the Expression of a Mutant Dihydrofolate Reductase under Control of Different Internal Promoters in Retroviral Vectors

  1992cited by this paper
• Evaluation of the Transfer and Expression in Mice of an Enzyme-Encoding Gene Using a Human Adenovirus Vector

  1990cited by this paper
• Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

  1981cited by this paper

• Gene therapy for age-related macular degeneration: a promising frontier in vision preservation

  2025cites this paper
• Strategies for Modifying Adenoviral Vectors for Gene Therapy

  2024cites this paper
• Clinical and Translational Landscape of Viral Gene Therapies

  2024cites this paper
• Role of Adenoviruses in Cancer Therapy

  2022cites this paper
• Locked and loaded: engineering and arming oncolytic adenoviruses to enhance anti-tumor immune responses

  2022cites this paper
• A New Look at Vaccine Strategies Against PPRV Focused on Adenoviral Candidates

  2021cites this paper
• Understanding Post Entry Sorting of Adenovirus Capsids; A Chance to Change Vaccine Vector Properties

  2021cites this paper
• Gene Therapy for Choroidal Neovascularization

  2020cites this paper
• Adenovirus Vector–Induced IL-6 Promotes Leaky Adenoviral Gene Expression, Leading to Acute Hepatotoxicity

  2020cites this paper
• Gene Therapy Approaches for Cochlear Repair

  2020cites this paper
• The Evolution of Gene Therapy in the Treatment of Metabolic Liver Diseases

  2020cites this paper
• High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy

  2020influential citation
• A New Gorilla Adenoviral Vector with Natural Lung Tropism Avoids Liver Toxicity and Is Amenable to Capsid Engineering and Vector Retargeting

  2020cites this paper
• Advances in Alpha-1 Antitrypsin Gene Therapy.

  2020cites this paper
• Alpha 1 antitrypsin deficiency: a rare multisystem disease, predominantly affecting the lung

  2019cites this paper
• Gene Therapy in Pediatric Liver Disease

  2019cites this paper
• Chapter 4 Adenoviral Vector-Based Vaccines and Gene Therapies : Current Status and Future Prospects

  2019cites this paper
• CAV-2 Vector Development and Gene Transfer in the Central and Peripheral Nervous Systems

  2019cites this paper
• Impact of silencing hepatic SREBP-1 on insulin signaling

  2018cites this paper
• Precision gene editing technology and applications in nephrology

  2018cites this paper
• Adenoviral Vector-Based Vaccines and Gene Therapies: Current Status and Future Prospects

  2018cites this paper
• Chapter 14 – Gene Therapy

  2017cites this paper
• In Vivo Hematopoietic Stem Cell Transduction.

  2017cites this paper
• Adenovirus Vector Toxicity

  2017cites this paper
• Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.

  2017cites this paper
• Gene therapy for age-related macular degeneration

  2017cites this paper
• Genetic Modification of the Lung Directed Toward Treatment of Human Disease

  2017cites this paper
• Emerging Gene Therapies for Genetic Hearing Loss

  2017cites this paper
• Novel roles of sterol regulatory element-binding protein-1 in liver

  2016cites this paper
• Cloning and Large-Scale Production of High-Capacity Adenoviral Vectors Based on the Human Adenovirus Type 5.

  2016cites this paper
• Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

  2016cites this paper
• Ad 2.0: a novel recombineering platform for high-throughput generation of tailored adenoviruses

  2015cites this paper
• Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation

  2015cites this paper
• Aerosolized Medications for Gene and Peptide Therapy

  2015cites this paper
• Sterol Regulatory Element-binding Protein-1 (SREBP-1) Is Required to Regulate Glycogen Synthesis and Gluconeogenic Gene Expression in Mouse Liver*

  2014cites this paper
• Liver Gluconeogenic Gene Expression in Mouse Regulate Glycogen Synthesis and Protein-1 ( SREBP-1 ) Is Required to Sterol Regulatory Element-binding Gene Regulation :

  2014cites this paper
• α-1-Antitrypsin deficiency: clinical variability, assessment, and treatment.

  2014cites this paper
• The Role of Chromatin in Adenoviral Vector Function

  2013cites this paper
• PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice

  2013cites this paper
• Developing a HER3 Vaccine to Prevent Resistance to Endocrine Therapy

  2013cites this paper
• Comparison of Systemic and Mucosal Immunization with Helper-Dependent Adenoviruses for Vaccination against Mucosal Challenge with SHIV

  2013cites this paper
• Alpha-1 Antitrypsin Deficiency: New Developments in Augmentation and Other Therapies

  2013cites this paper
• Improvements in Gene Therapy

  2012cites this paper
• Viral and nonviral delivery systems for gene delivery

  2012cites this paper
• New insights into stability of recombinant adenovirus vector genomes in mammalian cells.

  2012cites this paper
• Delivery Systems for Pulmonary Gene Therapy

  2012cites this paper
• Adenovirus-based gene therapy approaches for hemophilia B

  2012cites this paper
• Vector and Helper Genome Rearrangements Occur During Production of Helper-Dependent Adenoviral Vectors

  2012cites this paper
• Cytokine Protocols

  2012cites this paper
• shRNA-induced interferon-stimulated gene analysis.

  2012cites this paper
• Alternative approaches for the treatment of adenovirus infections

  2012cites this paper
• Short Communication Transcriptional activity of inverted terminal repeats of various human adenovirus serotypes

  2011cites this paper
• Gene Delivery Using Viral Vectors

  2011cites this paper
• RNAi‐Mediated Therapeutics

  2011cites this paper
• Gene Therapy for Alpha-1-Antitrypsin Deficiency Diseases

  2011cites this paper
• Genetic engineering of adenoviral vectors for improved therapeutic applications

  2011cites this paper
• Immune Recognition of Gene Transfer Vectors: Focus on Adenovirus as a Paradigm

  2011cites this paper
• Rescue administration of a helper-dependent adenovirus vector with long-term efficacy in dogs with glycogen storage disease type Ia

  2011cites this paper
• Construction and evaluation of high-capacity adenoviral vectors for gene therapy applications

  2011cites this paper
• Constitutive Expression of Short Hairpin RNA in Vivo Triggers Buildup of Mature Hairpin Molecules

  2011cites this paper
• Adenoviral vector immunity: its implications and circumvention strategies.

  2011cites this paper
• Assembly of Helper-Dependent Adenovirus DNA into Chromatin Promotes Efficient Gene Expression

  2011cites this paper
• Neonatal helper-dependent adenoviral vector gene therapy mediates correction of hemophilia A and tolerance to human factor VIII

  2011cites this paper
• miRNA cassettes in viral vectors: problems and solutions.

  2011cites this paper
• Delivery of Helper-dependent Adenoviral Vectors to the Subretinal Space of Mice

  2010cites this paper
• New Strategies in Drug Development Focusing on the Anti-Protease- Protease Balance in Alpha-1 Antitrypsin Deficiency

  2010cites this paper
• Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B.

  2010cites this paper
• Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activators

  2010cites this paper
• Rescue, amplification, purification, and PEGylation of replication defective first-generation adenoviral vectors.

  2010cites this paper
• Production of adenovirus vectors and their use as a delivery system for influenza vaccines

  2010cites this paper
• Persistence of High-Capacity Adenoviral Vectors as Replication-Defective Monomeric Genomes In Vitro and in Murine Liver

  2009cites this paper
• Methods, potentials, and limitations of gene delivery to regenerate central nervous system cells

  2009cites this paper
• The persistence of recombinant adenoviral vectors

  2009cites this paper
• Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector.

  2009cites this paper
• Comparison of Replication-Competent, First Generation, and Helper-Dependent Adenoviral Vaccines

  2009cites this paper
• Lasting Reduction of Cocaine Action in Neostriatum— A Hydrolase Gene Therapy Approach

  2009cites this paper
• Exploiting the adenoassociated virus Rep protein to mediate site-specific integration into the human genome and optimisation of Ad/AAV vector design

  2008cites this paper
• Modelling and treating Huntington’s disease: Generation of high-capacity adenovirus vectors to express normal and mutant huntingtin and to block huntingtin expression by short hairpin interference RNA

  2008cites this paper
• Short-Term Rescue of Neonatal Lethality in a Mouse Model of Propionic Acidemia by Gene Therapy

  2008cites this paper
• Targeting of adenovirus vectors to the LRP receptor family with the high-affinity ligand RAP via combined genetic and chemical modification of the pIX capsomere.

  2008cites this paper
• Helper-dependent Adenovirus-mediated Short Hairpin RNA Expression in the Liver Activates the Interferon Response*

  2008cites this paper
• Recombinant adenovirus as a methodology for exploration of physiologic functions of growth factor pathways

  2008cites this paper
• Persistent expression of PEDF in the eye using high-capacity adenovectors.

  2008cites this paper
• Robust Hepatic Gene Silencing for Functional Studies Using Helper-Dependent Adenoviral Vectors

  2008cites this paper
• Max-von-Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie

  2008cites this paper
• Fibrin(ogen) - ein neuer Träger für nicht virale Genvektoren

  2008cites this paper
• Chromosomal integration in vitro and in vivo of high capacity adenoviral vectors

  2007cites this paper
• Transient activation of transgene expression by hydrodynamics-based injection may cause rapid decrease in plasmid DNA expression

  2007cites this paper
• Expression of pIX Gene Induced by Transgene Promoter: Possible Cause of Host Immune Response in First-Generation Adenoviral Vectors

  2007cites this paper
• Antigen-Specific Tolerance of Human α 1-Antitrypsin Induced by Helper-Dependent Adenovirus

  2007cites this paper
• Fiber-Modified Adenovirus Vectors Decrease Liver Toxicity through Reduced IL-6 Production1

  2007cites this paper
• Correction of murine hemophilia A and immunological differences of factor VIII variants delivered by helper-dependent adenoviral vectors.

  2007cites this paper
• Helper-Dependent Adenovirus-Mediated Gene Transfer Into the Adult Mouse Cochlea

  2007cites this paper
• Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors.

  2007cites this paper
• Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy.

  2007cites this paper
• Alpha One Antitrypsin Deficiency: From Gene to Treatment

  2007cites this paper
• Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector

  2007cites this paper
• Improved Hepatic Transduction, Reduced Systemic Vector Dissemination, and Long-Term Transgene Expression by Delivering Helper-Dependent Adenoviral Vectors into the Surgically Isolated Liver of Nonhuman Primates

  2006cites this paper
• Dendritic Cell-Based Genetic Immunotherapy for Ovarian Cancer

  2006cites this paper
• Quantification of High-Capacity Helper-Dependent Adenoviral Vector Genomes In Vitro and In Vivo, Using Quantitative TaqMan Real-Time Polymerase Chain Reaction

  2006cites this paper